4.6 Article

Analyses of Intravesicular Exosomal Proteins Using a Nano-Plasmonic System

Journal

ACS PHOTONICS
Volume 5, Issue 2, Pages 487-494

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsphotonics.7b00992

Keywords

surface plasmon resonance; extracellular vesicles; exosomes; nanohole arrays; biomarlcers; cancer

Funding

  1. NIH [R21-CA205322, R01-HL113156, K99-CA201248, ROI-CA204019, R01-EB010011, R01-EB00462605A1, P01-CA069246]
  2. Liz Tilberis Award Fund
  3. MGH scholar fund
  4. Andrew L. Warshaw, M.D. Institute for Pancreatic Cancer Research
  5. Lustgarten Foundation
  6. National Research Foundation of Korea [NRF-2017M3A9B4025699, NRF-2017M3A9B4025709]
  7. Basic Science Research Program by the Ministry of Education, South Korea [NRF-2014R1A6A3A03060030]
  8. NATIONAL CANCER INSTITUTE [P01CA069246, R00CA201248, K99CA201248, R01CA204019, R21CA205322] Funding Source: NIH RePORTER
  9. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113156] Funding Source: NIH RePORTER
  10. NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB004626, R01EB010011] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Extracellular vesicles (EVs), including exosomes, are nanoscale membrane particles shed from cells and contain cellular proteins whose makeup could inform cancer diagnosis and treatment. Most analyses have focused on surface proteins while analysis of intravesicular proteins has been more challenging. Herein, we report an EV screening assay for both intravesicular and transmembrane proteins using a nanoplasmonic sensor. Termed iNPS (intravesicular nanoplasmonic system), this platform used nanohole-based surface plasmon resonance (SPR) for molecular detection. Specifically, we (i) established a unified assay protocol to detect intravesicular as well as transmembrane proteins; and (ii) engineered plasmonic substrates to enhance detection sensitivity. The resulting iNPS enabled sensitive (0.5 mu L sample per marker) and high-throughput (a 10 x 10 array) detection for EV proteins. When applied to monitor EVs from drug-treated cancer cells, the iNPS assay revealed drug-dependent unique EV protein signatures. We envision that iNPS could be a powerful tool for comprehensive molecular screening of EVs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available